SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey
dc.contributor.author | Oygar, PD | |
dc.contributor.author | Büyükçam, A | |
dc.contributor.author | Bal, ZS | |
dc.contributor.author | Dalgiç, N | |
dc.contributor.author | Bozdemir, SE | |
dc.contributor.author | Karbuz, A | |
dc.contributor.author | Çetin, BS | |
dc.contributor.author | Kara, Y | |
dc.contributor.author | Çetin, C | |
dc.contributor.author | Hatipoglu, N | |
dc.contributor.author | Uygun, H | |
dc.contributor.author | Aygün, FD | |
dc.contributor.author | Törün, SH | |
dc.contributor.author | Okur, DS | |
dc.contributor.author | Çiftdogan, DY | |
dc.contributor.author | Kara, TT | |
dc.contributor.author | Yahsi, A | |
dc.contributor.author | Özer, A | |
dc.contributor.author | Demir, SÖ | |
dc.contributor.author | Akkoç, G | |
dc.contributor.author | Turan, C | |
dc.contributor.author | Sali, E | |
dc.contributor.author | Sen, S | |
dc.contributor.author | Erdeniz, EH | |
dc.contributor.author | Kara, SS | |
dc.contributor.author | Emiroglu, M | |
dc.contributor.author | Erat, T | |
dc.contributor.author | Aktürk, H | |
dc.contributor.author | Gürlevik, SL | |
dc.contributor.author | Sütçü, M | |
dc.contributor.author | Aydin, ZGG | |
dc.contributor.author | Atikan, BY | |
dc.contributor.author | Yesil, E | |
dc.contributor.author | Güner, G | |
dc.contributor.author | Çelebi, E | |
dc.contributor.author | Efe, K | |
dc.contributor.author | Isançli, DK | |
dc.contributor.author | Durmus, HS | |
dc.contributor.author | Tekeli, S | |
dc.contributor.author | Karaaslan, A | |
dc.contributor.author | Bülbül, L | |
dc.contributor.author | Almis, H | |
dc.contributor.author | Kaba, Ö | |
dc.contributor.author | Keles, YE | |
dc.contributor.author | Yazicioglu, B | |
dc.contributor.author | Oguz, SB | |
dc.contributor.author | Ovali, HF | |
dc.contributor.author | Dogan, HH | |
dc.contributor.author | Çelebi, S | |
dc.contributor.author | Çakir, D | |
dc.contributor.author | Karasulu, B | |
dc.contributor.author | Alkan, G | |
dc.contributor.author | Yenidogan, I | |
dc.contributor.author | Gül, D | |
dc.contributor.author | Küçükalioglu, BP | |
dc.contributor.author | Avcu, G | |
dc.contributor.author | Kukul, MG | |
dc.contributor.author | Bilen, M | |
dc.contributor.author | Yasar, B | |
dc.contributor.author | Üstün, T | |
dc.contributor.author | Kiliç, Ö | |
dc.contributor.author | Akin, Y | |
dc.contributor.author | Cebeci, SO | |
dc.contributor.author | Bucak, IH | |
dc.contributor.author | Yanartas, MS | |
dc.contributor.author | Sahin, A | |
dc.contributor.author | Arslanoglu, S | |
dc.contributor.author | Elevli, M | |
dc.contributor.author | Çoban, R | |
dc.contributor.author | Öz, SKT | |
dc.contributor.author | Hatipoglu, H | |
dc.contributor.author | Erkum, IT | |
dc.contributor.author | Turgut, M | |
dc.contributor.author | Demirbuga, A | |
dc.contributor.author | Özçelik, T | |
dc.contributor.author | Çiftçi, D | |
dc.contributor.author | Sari, EE | |
dc.contributor.author | Akkus, G | |
dc.contributor.author | Hatipoglu, SS | |
dc.contributor.author | Dinleyici, EÇ | |
dc.contributor.author | Hacimustafaoglu, M | |
dc.contributor.author | Özkinay, F | |
dc.contributor.author | Kurugöl, Z | |
dc.contributor.author | Cengiz, AB | |
dc.contributor.author | Somer, A | |
dc.contributor.author | Tezer, H | |
dc.contributor.author | Kara, A | |
dc.date.accessioned | 2024-07-18T12:08:37Z | |
dc.date.available | 2024-07-18T12:08:37Z | |
dc.description.abstract | Background: Understanding SARS-CoV-2 seroprevalence among health care personnel is important to ex-plore risk factors for transmission, develop elimination strategies and form a view on the necessity and frequency of surveillance in the future. Methods: We enrolled 4927 health care personnel working in pediatric units at 32 hospitals from 7 different regions of Turkey in a study to determine SARS Co-V-2 seroprevalence after the first peak of the COVID-19 pandemic. A point of care serologic lateral flow rapid test kit for immunoglobulin (Ig)M/IgG was used. Seroprevalence and its association with demographic characteristics and possible risk factors were analyzed. Results: SARS-CoV-2 seropositivity prevalence in health care personnel tested was 6.1%. Seropositivity was more common among those who did not universally wear protective masks (10.6% vs 6.1%). Having a COVID-19-positive co-worker increased the likelihood of infection. The least and the most experienced personnel were more likely to be infected. Most of the seropositive health care personnel (68.0%) did not suspect that they had previously had COVID-19. Conclusions: Health surveillance for health care personnel involving routine point-of-care nucleic acid testing and monitoring personal protective equipment adherence are suggested as important strategies to protect health care personnel from COVID-19 and reduce nosocomial SARS-CoV-2 transmission. (C) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. | |
dc.identifier.issn | 1201-9712 | |
dc.identifier.other | 1878-3511 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/11012 | |
dc.language.iso | English | |
dc.publisher | ELSEVIER SCI LTD | |
dc.title | SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey | |
dc.type | Article |